Nepsis Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Buy
143,946
+54,507
+61% +$4.4M 3.82% 18
2026
Q1
$7.75M Buy
89,439
+743
+0.8% +$71.2K 2.6% 20
2025
Q4
$8.52M Buy
+88,696
New +$8.62M 2.63% 22
2018
Q2
Sell
-18,418
Closed -$1.48M 40
2018
Q1
$1.48M Sell
18,418
-14,865
-45% -$1.23M 0.78% 35
2017
Q4
$2.69M Sell
33,283
-9,412
-22% -$754K 1.36% 29
2017
Q3
$3.32M Sell
42,695
-6,197
-13% -$514K 1.71% 30
2017
Q2
$4.34M Sell
48,892
-3,824
-7% -$322K 2.14% 29
2017
Q1
$4.25M Sell
52,716
-11,572
-18% -$904K 2.18% 28
2016
Q4
$4.58M Buy
64,288
+2,151
+3% +$169K 2.62% 23
2016
Q3
$5.37M Buy
62,137
+2,231
+4% +$194K 2.92% 18
2016
Q2
$5.2M Sell
59,906
-4,762
-7% -$385K 2.96% 20
2016
Q1
$4.85M Sell
64,668
-16,810
-21% -$1.27M 2.6% 20
2015
Q4
$6.27M Sell
81,478
-2,862
-3% -$215K 3.64% 15
2015
Q3
$5.65M Buy
84,340
+2,523
+3% +$186K 3.36% 14
2015
Q2
$6.04M Buy
81,817
+2,622
+3% +$200K 4.07% 10
2015
Q1
$6.18M Sell
79,195
-1,502
-2% -$114K 3.73% 9
2014
Q4
$5.83M Sell
80,697
-2,347
-3% -$163K 3.4% 13
2014
Q3
$4.04M Buy
83,044
+603
+0.7% +$38.3K 2.31% 11
2014
Q2
$5.27M Buy
82,441
+1,642
+2% +$99.7K 2.9% 16
2014
Q1
$4.98M Buy
80,799
+6,376
+9% +$371K 3.03% 14
2013
Q4
$4.27M Buy
+74,423
New +$4.22M 2.95% 14

Other funds holding MDT

Nepsis Inc's MDT Position: Q2 2026 in Review

Nepsis Inc increased its Medtronic (MDT) stake by 61% in Q2 2026, buying an estimated $4.4M and bringing the position to 143,946 shares worth $11.3M. The position accounts for 3.82% of the portfolio, ranked #18.

Nepsis Inc first reported a position in MDT in Q4 2013 and has held it in 21 quarters since. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Nepsis Inc held 143,946 shares of Medtronic worth $11.3M as of Q2 2026.
  • Nepsis Inc bought 54,507 Medtronic shares in Q2 2026, an estimated $4.4M.
  • Medtronic made up 3.82% of Nepsis Inc's portfolio in Q2 2026, its #18 holding.
  • Nepsis Inc first reported a position in Medtronic in Q4 2013 and has held it in 21 quarters since.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Nepsis Inc's 13F filing for Q2 2026, filed 14 Jul 2026.